On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.
More Latest News
October 23, 2020
Click here to view the full requirements for the Nonresident Sterile Compounding renewal for Nonresident Pharmacies and Outsourcing Facilities. Continue reading
October 2, 2020
Emergency Order DOH No. 20-014 allows licensed pharmacists and registered pharmacy interns to administer FDA approved vaccines to individuals, including those under 18 years of age. Continue reading